Liquid Biopsy Spots Early Liver Cancer in Patients With HBV Infection Liquid Biopsy Spots Early Liver Cancer in Patients With HBV Infection
In high-risk patients with asymptomatic hepatitis B virus (HBV) infection, a liquid biopsy shows promise in detecting early-stage hepatocellular carcinoma (HCC), according to Chinese and U.S. researchers.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 21, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Aspirin May Lower HCC Risk in Patients With Hepatitis B Aspirin May Lower HCC Risk in Patients With Hepatitis B
A new study finds that daily low-dose aspirin may decrease the risk for hepatocellular carcinoma in patients with chronic hepatitis B infection.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - March 19, 2019 Category: Infectious Diseases Tags: Gastroenterology News Source Type: news

HBV-Related Liver Cancer and the Role of Aspirin
(MedPage Today) -- Daily dose tied to 29% lower risk of developing common hepatitis B complications (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 18, 2019 Category: Gastroenterology Source Type: news

Hepatitis B virus sheds light on ancient human population movements into Australia
(University of Melbourne) Australian researchers have used hepatitis B virus genome sequences to deduce that the mainland Aboriginal population separated from other early humans at least 59,000 years ago. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 17, 2019 Category: Biology Source Type: news

Antiviral therapy improves survival rates for kidney transplant recipients with hepatitis B or C
(Elsevier) Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B (HBV) or hepatitis C (HCV) experienced poor outcomes. In a new study in the Journal of Hepatology, published by Elsevier, researchers report favorable 10-year survival rates for patients with HBV and/or HCV treated with antiviral agents and advise that antiviral therapy should be systematically offered to all HBV and HCV patients in line with international recommendations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 14, 2019 Category: Infectious Diseases Source Type: news

Hepatitis B vaccination in preadolescents lowered the disease incidence rate in Catalonia
(University of Barcelona) Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent according to a study in which the University of Barcelona took part. The study analyzed the efficiency and impact of the vaccination program set in Catalonia, Spain, 21 years ago. The results show that after introducing the program, the incidence rate in general population went from 2.5 per 100,000 people in 1991 to 1.2 per 100,000 people in 2014. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 13, 2019 Category: International Medicine & Public Health Source Type: news

Stopping Oral Antiviral Therapy in Chronic Hep B Possible for Some People Stopping Oral Antiviral Therapy in Chronic Hep B Possible for Some People
A new analysis provides insight into what happens after stopping tenofovir disoproxil fumarate (TDF) in chronic hepatitis B patients with persistent viral suppression who took the drug for at least eight years.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 1, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Abbott Introduces the World's Most Sensitive Rapid Diagnostic Test, Determine ™ HBsAg 2, to Accelerate Hepatitis B Care
- New point-of-care rapid test identifies and helps make effective care more accessible for millions of people living with hepatitis B, in support of World Health Organization (WHO) hepatitis targets (Source: Abbott.com)
Source: Abbott.com - February 20, 2019 Category: Pharmaceuticals Source Type: news

Disturbing study reveals connection between brain damage and hepatitis B vaccine
(Natural News) The hepatitis B vaccine is routinely administered to newborns, often just a few short hours after birth. It’s a highly controversial practice; for many parents, the idea of vaccinating a delicate, newborn baby has been a hard pill to swallow. Now, new research confirms there is a link between the hepatitis B vaccine... (Source: NaturalNews.com)
Source: NaturalNews.com - February 17, 2019 Category: Consumer Health News Source Type: news

Uganda: All Medics to Be Immunised Against Hepatitis B - Health Ministry
[Monitor] The Ministry of Health has issued a directive to all health facilities to have their medical personnel immunised against the Hepatitis B disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 12, 2019 Category: African Health Source Type: news

Chinese Blood Plasma Feared Contaminated With HIV Tests Negative, Investigators Say
(BEIJING) — Chinese investigators said Thursday tests on a batch of a plasma product feared to have been contaminated with HIV have turned up negative for the virus that causes AIDS. The result appears to have headed off the possibility of yet another scandal involving medical products in the country. Incidents include the falsifying of production records for rabies vaccines that prompted a nationwide crackdown on the industry and the injecting of other faulty vaccines. Public outrage over such scandals has alarmed the leadership of the ruling Communist Party, moving it to respond more quickly and firmly than in the ...
Source: TIME: Health - February 7, 2019 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized China onetime Source Type: news

2019 ACIP Schedule Updates Influenza, Hepatitis Vaccine Recs 2019 ACIP Schedule Updates Influenza, Hepatitis Vaccine Recs
The schedule also includes updated recommendations for influenza and hepatitis B vaccines.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 4, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Many Cancer Patients Have Undiagnosed Hepatitis
The findings suggest screening for hepatitis B and C may be appropriate in community cancer clinics. (Source: WebMD Health)
Source: WebMD Health - January 25, 2019 Category: Consumer Health News Source Type: news

Many Cancer Patients Have Undiagnosed Hepatitis
FRIDAY, Jan. 25, 2019 -- A large number of U.S. cancer patients with hepatitis B and C don't know they have the virus, which can cause life-threatening complications during some cancer treatments, researchers say. The findings suggest screening for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 25, 2019 Category: General Medicine Source Type: news

CDC: Proportion of Increased-Risk Deceased Organ Donors on Rise
THURSDAY, Jan. 24, 2019 -- Among deceased organ donors, there has been an increase in the proportion at increased risk for transmitting hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV to recipients, according to research published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2019 Category: Pharmaceuticals Source Type: news

Prevalence of Chronic Hepatitis B and C Infection in Mongolian Immigrants in the Washington, District of Columbia, Metropolitan Area, 2016-2017
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - January 24, 2019 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Many New Cancer Patients Unaware of Their Hepatitis Status
TUESDAY, Jan. 22, 2019 -- A substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are unaware of their viral infection at the time of cancer diagnosis, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 22, 2019 Category: Pharmaceuticals Source Type: news

Socioeconomic vulnerability to depressive symptoms in patients with chronic hepatitis B - Vu TTM, Le TV, Dang AK, Nguyen LH, Nguyen BC, Tran BX, Latkin CA, Ho CSH, Ho RCM.
Depression is considered one of the most prevalent psychiatric disorders among patients with hepatitis B virus (HBV)-related liver disease and has adverse effects on the disease progression. However, there is a scarcity of studies contributing to the asses... (Source: SafetyLit)
Source: SafetyLit - January 21, 2019 Category: International Medicine & Public Health Tags: Social Etiologies and Disparities Source Type: news

Hepatitis B | Medscape Hepatitis B | Medscape
Review in-depth clinical information, latest medical news, and guidelines on hepatitis B infection. Read the latest on prevention of hepatitis B virus with the hepatitis B vaccine. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news

Medical News Today: What are the possible side effects of the hepatitis B vaccine?
Side effects of the hepatitis B vaccine can include nausea, vomiting, and diarrhea. There may also be no side effects at all. Learn more about the possible side effects of the hepatitis B vaccine here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 17, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Uganda: Government On Course With Hepatitis B Vaccinations
[Independent (Kampala)] Kampala, Uganda -Government is carrying out vaccinations of adults infected with Chronic Hepatitis B (CHB) majorly in the North and North Eastern regions, as efforts are made to extend the treatment to other regions of the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 17, 2019 Category: African Health Source Type: news

Many hepatitis infections go undiagnosed in cancer patients
(SWOG) Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but treatable viral infections that cancer patients should know they have - because these viruses can cause life-threatening complications when certain cancer treatments are used. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 16, 2019 Category: Drugs & Pharmacology Source Type: news

Screen Pregnant Women for HBV at First Prenatal Visit
The U.S. Preventive Services Task Force posted a draft recommendation statement and draft evidence review on Jan. 8 that discussed screening pregnant women for hepatitis B virus infection. (Source: AAFP News)
Source: AAFP News - January 14, 2019 Category: Primary Care Source Type: news

Medical News Today: Benefits of the hepatitis B vaccine for newborns
Newborns receive the hepatitis B vaccine to prevent them from contracting the hepatitis B virus during their lifetime. Learn more about the benefits of the hepatitis B vaccine here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 9, 2019 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

USPSTF: Screen All Pregnant Women Early for Hepatitis B
(MedPage Today) -- Task force reaffirms 2009 recommendation; draft currently open to comment (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - January 8, 2019 Category: Pediatrics Source Type: news

USPSTF Affirms Guidance for Hep B Screening at First Prenatal Visit
TUESDAY, Jan. 8, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommends hepatitis B virus (HBV) infection screening in pregnant women at their first prenatal visit. These findings form the basis of a draft recommendation statement... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2019 Category: Pharmaceuticals Source Type: news

Woman First to Claim Infection After Surgery at New Jersey Facility Woman First to Claim Infection After Surgery at New Jersey Facility
A former patient at a New Jersey surgical facility that state health officials said may have exposed thousands of patients to HIV and other blood-borne pathogens has tested positive for hepatitis B, one of her lawyers said on Thursday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

First victim of New Jersey infection scandal: Woman tests positive for hepatitis B
The unidentified patient is the first to sue HealthPlus Surgery Center in Saddle Brook, New Jersey, which says up to 3,778 people were exposed to HIV, hepatitis, and other blood-borne pathogens. (Source: the Mail online | Health)
Source: the Mail online | Health - January 3, 2019 Category: Consumer Health News Source Type: news

Woman first to claim infection after surgery at New Jersey facility
A former patient at a New Jersey surgical facility that state health officials said may have exposed thousands of patients to HIV and other blood-borne pathogens has tested positive for hepatitis B, one of her lawyers said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - January 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Woman tests positive for hepatitis B after surgery center warning
A Brooklyn woman has tested positive for hepatitis B after having a procedure at a New Jersey surgery center that later warned thousands of patients they may have been exposed to blood-borne pathogens like hepatitis B, hepatitis C and HIV. (Source: CNN.com - Health)
Source: CNN.com - Health - January 3, 2019 Category: Consumer Health News Source Type: news

Over 3700 surgical patients may have been exposed to HIV in New Jersey, proving yet again that hospitals are dangerous to your health
(Natural News) Thousands of patients may have contracted HIV, hepatitis B, or hepatitis C – or possibly all of the above – while being treated at HealthPlus Surgery Center in Saddle Brook, New Jersey, shocking new reports indicate. A lengthy investigation by the New Jersey State Department of Health has revealed that the ambulatory surgery... (Source: NaturalNews.com)
Source: NaturalNews.com - December 30, 2018 Category: Consumer Health News Source Type: news

New Jersey Urges Patients At Facility to Check for HIV Infections New Jersey Urges Patients At Facility to Check for HIV Infections
New Jersey health officials have urged more than 3,700 former patients of a surgical facility to get blood tests"out of an abundance of caution," because they may have been exposed to HIV, hepatitis B and hepatitis C.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 26, 2018 Category: Infectious Diseases Tags: Family Medicine/Primary Care News Source Type: news

Surgery center alerts 3,778 patients about possible infections
Health officials want people to get tested for HIV, Hepatitis B and Hepatitis C (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 26, 2018 Category: Consumer Health News Source Type: news

Surgery Center May Have Infected Thousands
After an investigation, a New Jersey outpatient surgery center is urging anyone treated there between Jan. 1 and Sept. 7, 2018, be tested for HIV and hepatitis B and C. (Source: WebMD Health)
Source: WebMD Health - December 26, 2018 Category: Consumer Health News Source Type: news

More than 3,000 Patients Possibly Exposed to HIV and Hepatitis At New Jersey Surgical Center, Officials Say
A New Jersey surgical center may have exposed more than 3,000 patients to HIV and hepatitis, state officials said. People who received a procedure at the HealthPlus Surgery Center in Saddle Brook, New Jersey between Jan. 1 and Sept. 7 have been requested to take a blood test for HIV, hepatitis B and hepatitis C after “deficiencies in infection control” in the medical center’s cleaning and medication injection processes put them at risk. No infections or illnesses have been reported so far, HealthPlus Surgery Center administrator Betty McCabe said in a statement. Even so, health officials recommend patient...
Source: TIME: Health - December 26, 2018 Category: Consumer Health News Authors: Mahita Gajanan Tags: Uncategorized New Jersey onetime public health Source Type: news

Surgery center alerts 3,778 patients about possible exposure to infections
Health officials want people to get tested for HIV, Hepatitis B and Hepatitis C (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 26, 2018 Category: Consumer Health News Source Type: news

New Jersey urges patients at facility to check for HIV infections
New Jersey health officials have urged more than 3,700 former patients of a surgical facility to get blood tests "out of an abundance of caution," because they may have been exposed to HIV, hepatitis B and hepatitis C. (Source: Reuters: Health)
Source: Reuters: Health - December 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

WATCH: New Jersey surgery center possibly exposed thousands of patients to HIV, hepatitis
Over 3,000 patients of a surgery center in Bergen County, New Jersey, may have been exposed to HIV, hepatitis B and hepatitis C, according to the NJ Department of Health and HealthPlus Surgery Center. (Source: ABC News: Health)
Source: ABC News: Health - December 24, 2018 Category: Consumer Health News Tags: Health Source Type: news

Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load
Simplify Hepatitis B Treatment Management SUNNYVALE, Calif., Dec. 20, 2018 -- (Healthcare Sales & Marketing Network) -- Cepheid today announced the CE-IVD marking of Xpert HBV Viral Load, a new rapid test for the quantitation of Hepatitis B Virus (HBV)... Diagnostics, Regulatory, Product Launch Cepheid, Xpert HBV Viral Load, Hepatitis B Virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 20, 2018 Category: Pharmaceuticals Source Type: news

Optic Neuritis As the Only Manifestation of HBV Flare Optic Neuritis As the Only Manifestation of HBV Flare
This case demonstrates that auto-immune mediated optic neuritis may be a rare presentation of chronic hepatitis B virus infection.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2018 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Study suggests using Korean red ginseng to naturally remedy chronic hepatitis B
(Natural News) Conventional antiviral treatments, which aim to reduce viral replication, for chronic hepatitis B cause many side effects and resistance, so researchers continue to find safer and more effective alternatives. Since ginseng has been previously reported to be effective for treating viral infections such as influenza and human immunodeficiency virus, researchers from The Catholic... (Source: NaturalNews.com)
Source: NaturalNews.com - December 19, 2018 Category: Consumer Health News Source Type: news

CEO of Chapel Hill firm talks 2 new partnerships with big pharma
Chapel Hill-based Target PharmaSolutions is wrapping up 2018 with a pair of new partnerships, further pushing the fast-developing company toward what its CEO says will be a better 2019.   This month, the clinical data company announced strategic partnerships with Gilead Sciences (Nasdaq: GILD) and Bristol-Myers Squibb (NYSE: BMY) to expand its research work.  Gilead is the first partner to join the company’s Target-Hepatitis B study. It will also be entering the Target-NASH ( nonalcoholic fatty… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2018 Category: Pharmaceuticals Authors: Seth Gulledge Source Type: news

CEO of Chapel Hill firm talks 2 new partnerships with big pharma
Chapel Hill-based Target PharmaSolutions is wrapping up 2018 with a pair of new partnerships, further pushing the fast-developing company toward what its CEO says will be a better 2019.   This month, the clinical data company announced strategic partnerships with Gilead Sciences (Nasdaq: GILD) and Bristol-Myers Squibb (NYSE: BMY) to expand its research work.  Gilead is the first partner to join the company’s Target-Hepatitis B study. It will also be entering the Target-NASH ( nonalcoholic fatty… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Seth Gulledge Source Type: news

CEO of Chapel Hill firm talks 2 new partnerships with big pharma
Chapel Hill-based Target PharmaSolutions is wrapping up 2018 with a pair of new partnerships, further pushing the fast-developing company toward what its CEO says will be a better 2019.   This month, the clinical data company announced strategic partnerships with Gilead Sciences (Nasdaq: GILD) and Bristol-Myers Squibb (NYSE: BMY) to expand its research work.  Gilead is the first partner to join the company’s Target-Hepatitis B study. It will also be entering the Target-NASH ( nonalcoholic fatty… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 7, 2018 Category: Pharmaceuticals Authors: Seth Gulledge Source Type: news

CEO of Chapel Hill firm talks 2 new partnerships with big pharma
Chapel Hill-based Target PharmaSolutions is wrapping up 2018 with a pair of new partnerships, further pushing the fast-developing company toward what its CEO says will be a better 2019.   This month, the clinical data company announced strategic partnerships with Gilead Sciences (Nasdaq: GILD) and Bristol-Myers Squibb (NYSE: BMY) to expand its research work.  Gilead is the first partner to join the company’s Target-Hepatitis B study. It will also be entering the Target-NASH ( nonalcoholic fatty… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 7, 2018 Category: Biotechnology Authors: Seth Gulledge Source Type: news

Chronic hepatitis B virus infection
This Seminar describes the epidemiology of hepatitis B virus (HBV) infection, vaccination, pathophysiology, risk factors and management of chronic HBV infection, and existing controversies, concluding with a discussion of future prospects. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

Hepatitis B: vaccine recommendations during supply constraints
These recommendations say that the overall supply of hepatitis B vaccine to the UK has improved and vaccine is available for all indications. The temporary recommendations and other related documents will remain on gov.uk in case of future supply constraints as the same principles of prioritisation will apply. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

New Viral Biomarkers for HBV: Are We Able to Change Practice? New Viral Biomarkers for HBV: Are We Able to Change Practice?
Many biomarkers for hepatitis B are now available, including HBV DNA, HBsAg, HBV RNA, HBcrAg, and more. How might they help guide the treatment of patients with chronic HBV infection?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 23, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news